Results 1 to 10 of about 40,778 (241)

Study protocol for the DISTINCT trial: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one-size-fits-all’ approach in patients undergoing Total hIp or total kNee replaCemenT – a national, multicentre, randomised, multiarm, open-label trial [PDF]

BMJ Open
Introduction Patients undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA) are considered to have a symptomatic venous thromboembolism (VTE) risk of 1.0%–1.5% despite thromboprophylaxis.
Rob G H H Nelissen, Rolf H H Groenwold, Suzanne C Cannegieter, Menno V Huisman, Frederikus A Klok, Wilbert B van den Hout, Leti van Bodegom-Vos, Banne Nemeth, Nienke van Rein, Ruben Y Kok, Harmen B Ettema, Merel van Veen, Stephan B W Vehmeijer, Jan Joost I Wiegerinck   +13 more
doaj   +2 more sources

Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis

World Journal of Surgical Oncology
Background Direct oral anticoagulants (DOACs) used as an alternative to low-molecular-weight heparin (LMWH) for thromboprophylaxis after cancer surgery for venous thromboembolic events (VTE) remains unclear.
Hong Zhou, Ting-Ting Chen, Ling-ling Ye, Jun-Jie Ma, Jin-Hua Zhang   +4 more
doaj   +2 more sources

Effectiveness and Safety of Long-Term Venous Thromboembolism Prophylaxis After Colorectal Cancer Surgery: A Retrospective Study [PDF]

Drugs - Real World Outcomes
Background The optimal duration for thromboprophylaxis after colorectal cancer surgery remains uncertain. We sought to compare the effectiveness and safety of long-term thromboprophylaxis to that of short-term thromboprophylaxis in preventing venous ...
Ying Zhang, Xiaozhu Zhou, Yi Wu, Shicai Chen, Xiangli Cui, Ying Zhao   +5 more
doaj   +2 more sources

Thromboprophylaxis for trauma patients [PDF]

Cochrane Database of Systematic Reviews, 2010
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of thromboprophylaxis in trauma patients on mortality and incidence of DVT and PE. To compare the effects of different thromboprophylaxis interventions and their relative effects according to the type of trauma.
Barrera LM, Perel P, Ker K, CIROCCHI, Roberto, FARINELLA, ERIBERTO, Morales Uribe CH   +5 more
openaire   +10 more sources

STAMP: surgical thromboprophylaxis adherence management programme [PDF]

BMJ Open Quality
Introduction Venous thromboembolism is the main cause of preventable in-hospital morbidity and mortality. Despite the recommendations available in the clinical practice guideline, there is low adherence to correct thromboprophylaxis.
Natalia Quintana-Montejo, Paulo Andres Cabrera Rivera, Stefany de Jesús Ríos Acuña, Danna Lesley Cruz Reyes   +3 more
doaj   +2 more sources

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.

JAMA Internal Medicine, 2021
Importance Hospitalized patients with COVID-19 are at risk for venous and arterial thromboembolism and death. Optimal thromboprophylaxis dosing in high-risk patients is unknown. Objective To evaluate the effects of therapeutic-dose low-molecular-weight
A. Spyropoulos, M. Goldin, D. Giannis, W. Diab, Janice Wang, S. Khanijo, A. Mignatti, Eugenia Gianos, Marc Cohen, G. Sharifova, J. M. Lund, A. Tafur, P. A. Lewis, Kevin P. Cohoon, H. Rahman, C. Sison, M. Lesser, K. Ochani, Nirav Agrawal, J. Hsia, V. Anderson, M. Bonaca, J. Halperin, J. Weitz   +23 more
semanticscholar   +1 more source

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Blood Advances, 2021
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness are associated with a risk of venous thromboembolism (VTE).
A. Cuker, E. Tseng, R. Nieuwlaat, P. Angchaisuksiri, C. Blair, Kathryn E. Dane, Jennifer Davila, M. Desancho, D. Diuguid, D. Griffin, S. Kahn, F. Klok, A. Lee, I. Neumann, A. Pai, M. Pai, M. Righini, Kristen M. Sanfilippo, D. Siegal, M. Skara, Kamshad Touri, Elie A. Akl, Imad Bou Akl, M. Boulos, R. Brignardello-Petersen, R. Charide, M. Chan, K. Dearness, A. Darzi, Philipp Kolb, L. Colunga-Lozano, Razan Mansour, G. P. Morgano, R. Morsi, Atefeh Noori, Thomas Piggott, Yuan Qiu, Y. Roldan, Finn Schünemann, A. Stevens, K. Solo, M. Ventresca, W. Wiercioch, R. Mustafa, H. Schünemann   +44 more
semanticscholar   +1 more source

Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture.

New England Journal of Medicine, 2023
BACKGROUND Clinical guidelines recommend low-molecular-weight heparin for thromboprophylaxis in patients with fractures, but trials of its effectiveness as compared with aspirin are lacking.
R. O’Toole, D. Stein, N. O’Hara, K. Frey, Tara J Taylor, D. Scharfstein, A. Carlini, K. Sudini, Yasmin Degani, G. Slobogean, E. Haut, W. Obremskey, Reza Firoozabadi, M. Bosse, S. Goldhaber, Debra Marvel, R. Castillo   +16 more
semanticscholar   +1 more source

Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort

Research and Practice in Thrombosis and Haemostasis, 2021
Background Hospital‐associated venous thromboembolism (HA‐VTE) can be prevented by pharmacologic thromboprophylaxis. Thrombotic risk assessment models (RAMs) are essential tools to improve inadequately prescribed thromboprophylaxis. Among cases of HA‐VTE,
Marc Blondon, Andreas Limacher, Marc Righini, Drahomir Aujesky, Marie Méan   +4 more
doaj   +1 more source

Thromboprophylaxis in Patients With COVID-19

Chest, 2022
For two years, the entire world has been grappling with the new challenge that is the COVID-19 pandemic. In December 2019 in China's largest province, Wuhan, Severe Acute Respiratory Syndrome- Coronavirus-2 (SARS-CoV-2), was detected in a patient with ...
L. Moores, T. Tritschler, Shari Brosnahan, M. Carrier, Jacob F. Collen, K. Doerschug, A. Holley, Jonathan M. Iaccarino, D. Jiménez, G. Legal, Parth M Rali, P. Wells   +11 more
semanticscholar   +2 more sources